Search global stocks & ETFs...Ctrl K
Learn Mode
A logo
Agilent Technologies IncA
$130.69
-$2.70 (-2.024%)
at close
$130.70
$0.01 (0.008%)
after hours · 8:35 PM
General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Updates
A
Stock Profile
Market Cap
$36.91B
Industry
Life Sciences Tools & Services
EPS (TTM)
$4.99
P/E (TTM)
26.10
Div & Yield
$1.02 (0.78%)
FCF Payout Ratio
26.50%
P/S (TTM)
5.10
P/B
5.18
Revenue Growth (TTM)
9.11%
EPS CAGR (3Y)
3.12%
Diluted Shares
283.00M
Ex-Dividend
2026-06-30
Next Earnings
08-25
Forward P/E
20.30
Payout Ratio
20.37%
P/FCF (TTM)
33.96
FCF Yield
2.94%
Earnings Yield
3.83%
Revenue CAGR (3Y)
0.90%
Recommended Metric
3.71
Good
Agilent Technologies Inc has grown revenue at 9.11% over the past year, which suggests sales are increasing. Also, it has a free cash flow margin of 15.03%, which suggests the company is very profitable.
Valuation Score
Key Score
1.00
Very Bad
Management
1.00
Very Bad

Growth
4.00
Good

Profitability
4.00
Good
Fin. Health
5.00
Very Good

Dividends
1.00
Very Bad

Analyst
2.00
Bad
Revenue
Earnings
Free Cash Flow
Insider Transactions
Explore Insider Tab ›
Buy Transactions
Sell Transactions
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$130.69
Baseline
High
$194.25
48.63%
Avg
$164.36
25.76%
Low
$141.40
8.19%
Analyst Ratings based on 28 Analysts
Strong Buy
7
25%
Buy
15
54%
Hold
6
21%
Sell
0
00%
Strong Sell
0
00%
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.Read More

IPO Date
1999-11-18

Industry
Life Sciences Tools & Services

Total Employees
18,000

Exchange
New York Stock Exchange, Inc.

Reporting Currency
USD

GICS
Life Sciences Tools & Services

GICS Sub
Life Sciences Tools & Services

GICS Sector
Health Care

GICS Group
Pharmaceuticals, Biotechnology & Life Sciences